Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$20,740,672
-$89,978,049 QoQ
Shares Held
82,422
-83.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#597
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clearbridge Investments, LLC holds $3,156,802,100 across 12 Drug Manufacturers - General names. ABBV ranks #7 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
5,343,260 | $1,357,027,741 | |
| 2 | AZN |
Astrazeneca PLC
|
5,021,518 | $952,180,243 | |
| 3 | LLY |
ELI LILLY & Co
|
483,528 | $579,958,037 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,088,957 | $137,578,827 | |
| 5 | MRK |
Merck & Co., Inc.
|
565,690 | $72,691,165 | |
| 6 | AMGN |
Amgen Inc
|
69,065 | $25,009,817 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
82,422 | $20,740,672 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
101,597 | $5,854,019 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,740,672 | 82,422 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $110,718,721 | 509,075 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $203,384,660 | 890,125 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $253,336,943 | 1,094,139 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $320,385,688 | 1,726,030 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $412,159,781 | 1,967,162 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $460,394,400 | 2,590,852 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $561,436,429 | 2,843,004 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $659,951,329 | 3,847,664 | Shares | Sole | 2024-08-27 | |
| 2024-03-31 | $756,583,252 | 4,154,768 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $610,987,666 | 3,942,619 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $555,218,986 | 3,724,802 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $473,727,790 | 3,516,127 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $538,941,847 | 3,381,702 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $534,729,350 | 3,308,764 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $459,887,072 | 3,426,623 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $512,313,001 | 3,344,953 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $562,833,923 | 3,471,926 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $517,281,618 | 3,820,396 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $416,053,834 | 3,856,993 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $456,753,397 | 4,054,984 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $450,327,228 | 4,161,220 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $456,050,437 | 4,256,187 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $384,785,147 | 4,393,026 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $419,630,156 | 4,274,090 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $60,241,452 | 790,674 | Shares | Defined | 2020-05-22 | |
| No filing history on record for this holder in this stock. | ||||||